| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/02/2002 | WO2002034882A2 Genes regulating programmed cell death |
| 05/02/2002 | WO2002034788A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | WO2002034782A2 Endozepine-like polypeptide nov1 and nucleic acid encoding the same |
| 05/02/2002 | WO2002034781A1 Human g-protein coupled diadenosine tetraphosphate receptor (ap4ar) |
| 05/02/2002 | WO2002034778A2 Baseb209 polypeptides and polynucleotides from haemophilus influenzae |
| 05/02/2002 | WO2002034777A1 Fusion proteins as immunization treatments of alzheimer's disease |
| 05/02/2002 | WO2002034773A2 Streptococcal genes |
| 05/02/2002 | WO2002034772A2 Novel compounds |
| 05/02/2002 | WO2002034771A2 Nucleic acids and proteins from streptococcus groups a & b |
| 05/02/2002 | WO2002034770A1 Identification of hla-dr restricted hcv epitopes |
| 05/02/2002 | WO2002034769A2 Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150 |
| 05/02/2002 | WO2002034768A2 Polypeptides and polynucleodides from haemophilus influenzae and their use |
| 05/02/2002 | WO2002034763A2 Mucin comprising vehicle for the transport of biologically-active agents |
| 05/02/2002 | WO2002034291A2 Compositions and methods for treating hematologic malignancies and multiple drug resistance |
| 05/02/2002 | WO2002034289A1 Modulating angiogenesis |
| 05/02/2002 | WO2002034288A2 Vaccine for treating allergy |
| 05/02/2002 | WO2002034287A2 Therapeutic vaccine formulations containing chitosan |
| 05/02/2002 | WO2002034253A1 Hair growth stimulant |
| 05/02/2002 | WO2002034239A1 Use of hydrophilic particles associated with antigens for preparing vaccine compositions |
| 05/02/2002 | WO2002034205A2 Using heat shock proteins to increase immune response |
| 05/02/2002 | WO2002034119A2 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | WO2002022080A3 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 05/02/2002 | WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 05/02/2002 | WO2002006460A3 Masp-2, a complement-fixing enzyme, and uses for it |
| 05/02/2002 | WO2001098361A3 Agonist anti-trk-c monoclonal antibodies |
| 05/02/2002 | WO2001096368A3 Use of coiled-coil structural scaffold to generate structure-specific peptides |
| 05/02/2002 | WO2001094586A3 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 05/02/2002 | WO2001091803A3 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 05/02/2002 | WO2001083555A3 Pain signaling molecules |
| 05/02/2002 | WO2001081582A3 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 05/02/2002 | WO2001077137A9 Albumin fusion proteins |
| 05/02/2002 | WO2001074900A3 Nuclear factor kb inducing factor |
| 05/02/2002 | WO2001070771A3 Acute neuronal induced calcium binding protein type 1 ligand |
| 05/02/2002 | WO2001068708A3 Human and humanized fap-alpha-specific antibodies |
| 05/02/2002 | WO2001064749A3 Method for preparing anti-mif antibodies |
| 05/02/2002 | WO2001062266A3 Use of dpp-iv inhibitors for the treatment of diabetes |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001060317A3 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 05/02/2002 | WO2001058957A3 Enhancing the circulating half-life of antibody-based fusion proteins |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001038394A3 Polypetptides and methods for thymic vaccination |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001007651A3 Transposon mediated differential hybridisation |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078960A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020052594 Method and kit for imaging and treating organs and tissues |
| 05/02/2002 | US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052478 Viricides to control virus replication and delay the onset of HIV-1-related disease symptoms; combined the protease cleavage site residues of the Gag/Gag-Pol precursor proteins and the virion-specific feature of Vpr; DNA construct |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052469 Amino acid sequences for use in detection and treatment of viral infection |
| 05/02/2002 | US20020052422 Oral drug delivery compositions and methods |
| 05/02/2002 | US20020052412 Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052329 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/02/2002 | US20020052321 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/02/2002 | US20020052318 Activated alpha-2-macroglobulin, 3-O-deacylated monophosphoryl lipid A and granulocyte macrophage colony stimulating factor |
| 05/02/2002 | US20020052316 Bax-mediated apoptosis modulating reagents and methods |
| 05/02/2002 | US20020052313 Enhances production and affinity of the antibodies in the animal, in response to the vaccine. |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052308 Nucleic acids, proteins and antibodies |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052025 RTVP based compositions and methods for the treatment of prostate cancer |
| 05/02/2002 | US20020052011 Method for evaluating and affecting male fertility |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |
| 05/02/2002 | US20020051980 Methods for modulating the activation of a lymphocyte expressed G protein coupled receptor involved in cell proliferation, autoimmunity and inflammation |
| 05/02/2002 | US20020051977 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/02/2002 | US20020051967 Retrovirus; for use as a tool in the diagnosis and prevention of viaral diseases |
| 05/02/2002 | US20020051966 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants through ectopic expression of the adenovirus protease |
| 05/02/2002 | US20020051813 Lipomatrix comprises atleast one phospholipid and composed of lipid lattices of stacked bilayers which, when hydrated, form liposomes, useful for producing highly potent vaccines against tumor antigens |
| 05/02/2002 | US20020051794 Comprising as adjuvant one or more salts formed with a Group 2 element or a group 4 element, titanum, zirconium, or hafnium, with given exclusions |
| 05/02/2002 | US20020051793 Lipoteichoic acid immunogenic compositions and methods of making and using thereof |
| 05/02/2002 | US20020051792 (CTLA-4, Cytotoxic T-Lymphocyte Antigen-4); vaccines, feline immunomodulators |
| 05/02/2002 | US20020051791 Administering anthrax toxin lethal factor (LF) or an immunogenic fragment thereof to the animal; vaccines |
| 05/02/2002 | US20020051790 Helicobacter pylori; antigen of given amino acid sequences; superoxide dismutase in the form of a vaccine |
| 05/02/2002 | US20020051788 For covalently linking carbohydrates and proteins under neutral conditions, by attaching double bonds to a carrier protein, and attaching a conjugated diene to a carbohydrate hapten, then coupling; vaccines |
| 05/02/2002 | US20020051787 Steroids, viricides, and anti-microbial neutralizing antibodies suspended in a carrier |
| 05/02/2002 | US20020051785 HER -2/neu overexpression abrogates growth inhibitory pathways |
| 05/02/2002 | US20020051784 Methods for modulating T cell unresponsiveness |
| 05/02/2002 | US20020051782 Anti-CCR2 antibodies and methods of use therefor |
| 05/02/2002 | US20020051781 CC-chemokine receptor 2 (CCR2) bound by an immunoglobulin or an antigen-binding fragment |
| 05/02/2002 | US20020051780 Bind at the same time to the T-cell receptor complex, to tumour- associated antigens on a tumour cell, and, via the Fc portion of the bispecific antibody |
| 05/02/2002 | US20020051770 Virus neutralizing level of antibodies |
| 05/02/2002 | US20020051768 Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| 05/02/2002 | US20020051765 Method of cancer treatment |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1202064A2 Method for detecting antibodies to and antigens of fungal and yeast exposures |
| 05/02/2002 | EP1201760A1 Influenza virus vector for human dendritic cells |
| 05/02/2002 | EP1201750A1 Synthetic viruses and uses thereof |
| 05/02/2002 | EP1201251A1 Stratified and cryogenically stored vaccines, process for their preparation |
| 05/02/2002 | EP1201250A1 Immunogenic compositions comprising liver stage malarial antigens |
| 05/02/2002 | EP1200832A1 Annexins and autoantibodies used as markers for cancer |
| 05/02/2002 | EP1200622A1 Adenovirus carrying gag gene hiv vaccine |